Clinical trial
Creatine Therapy for Huntington's Disease
NCT00026988 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00026988 |
|---|---|
| Title | Creatine Therapy for Huntington's Disease |
| Official title | Creatine Therapy for Huntington's Disease |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Huntington's Disease |
| Intervention type | Drug |
| Interventions | Creatine |
| Enrollment | 64 |
| Start date | Oct 1, 2001 |
| Completion | Jun 1, 2006 |
| First posted | Nov 16, 2001 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: